Paolo Cravedi1, Roslyn B Mannon, Giuseppe Remuzzi. Show Affiliations » 1. Mario Negri Institute, Pharmacological Research, Bergamo, Italy. p.cravedi@gmail.com
Abstract
Mesh: See more » AlemtuzumabAnimalsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/therapeutic useHumansKidney TransplantationLymphocyte Depletion/methods
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAlemtuzumab
Year: 2008 PMID: 18725917 DOI: 10.1038/ncpneph0914
Source DB: PubMed Journal: Nat Clin Pract Nephrol ISSN: 1745-8323